百万CAR-T进医保之后:商保转基本医保通道打开,放量验证才刚开始

同花顺
4 hours ago

药明巨诺的瑞基奥仑赛注射液进入基本医保目录的消息,让一位资深医药人士在11月14日难掩激动。他的判断很直接:这款CAR-T细胞药物明年销量会大涨。瑞基奥仑赛由此成为继诺西那生钠之后,又一款靠医保谈判打破高价壁垒的明星药物。动辄百万元的支付天花板被击穿后,创新药(886015)市场开始想象一个更大的问题——商保目录里的高值药品,能不能批量走通转入基本医保这条路。今年医保目录调整首次建立了“双目录”...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10